Trial
NCT04342689
The Role of Resistant Starch in COVID-19 Infection
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
University of Michigan
Condition
COVID-19
Intervention
Dietary Supplement containing resistant starch
Why stopped
Study was terminated due to low enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-05